Published in

Elsevier, BBA - Molecular Basis of Disease, 1(1812), p. 12-22, 2011

DOI: 10.1016/j.bbadis.2010.09.002

Links

Tools

Export citation

Search in Google Scholar

Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Complement is an essential component of innate immunity and a major trigger of inflammatory responses. A critical step in complement activation is the formation of the C3 convertase of the alternative pathway (AP), a labile bimolecular complex formed by activated fragments of the C3 and factor B components that is fundamental to provide exponential amplification of the initial complement trigger. Regulation of the AP C3 convertase is essential to maintain complement homeostasis in plasma and to protect host cells and tissues from damage by complement. During the last decade, several studies have associated genetic variations in components and regulators of the AP C3 convertase with a number of chronic inflammatory diseases and susceptibility to infection. The functional characterization of these protein variants has helped to decipher the critical pathogenic mechanisms involved in some of these complement related disorders. In addition, these functional data together with recent 3D structures of the AP C3 convertase have provided fundamental insights into the assembly, activation and regulation of the AP C3 convertase ; 11 páginas, 7 figuras, 1 tabla -- PAGS nros. 12-22 ; This work was funded by the Spanish Ministerio de Educación y Cultura (grants: SAF2008-00226, SAF2008-00451 and SAF2006-02948), the Ciber de Enfermedades Raras (INTRA/08/738.2), the Red Temática de Investigación Cooperativa en Cáncer (RD06/0020/1001), the Fundación Renal Iñigo Alvarez de Toledo; the Fundación Ramón Areces, the Human Frontiers Science Program (RGP39/2008), and the MRC UK Project Grant Ref G0701298